Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia

Virology

Volumn 417, Issue 2, 2011, Pages 281-292

  Hertel, Paula M ^a   Crawford, Sue E ^a   Finegold, Milton J ^a   Estes, Mary K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antigenemia; Bile ducts; Biliary atresia; Cholestasis; Fibrosis; Liver; Osteopontin; Pediatrics; Rotavirus

Indexed keywords

LIVER PROTEIN; OSTEOPONTIN; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BLOOD LEVEL; ARTICLE; BILE DUCT ATRESIA; CONTROLLED STUDY; DISEASE COURSE; FIBROSIS; IMMUNOLOGICAL PARAMETERS; MICROBIAL ACTIVITY; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ROTAVIRUS; UPREGULATION; VIRUS INACTIVATION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; BILIARY ATRESIA; DISEASE MODELS, ANIMAL; HUMANS; LIVER; LIVER CIRRHOSIS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OSTEOPONTIN; RODENT DISEASES; ROTAVIRUS INFECTIONS; UP-REGULATION; VIREMIA;

MURINAE; MUS; ROTAVIRUS;

EID: 80051943107     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.05.015     Document Type: Article

References (50)

1. Allen S.R., Jafri M., Donnelly B., McNeal M., Witte D., Bezerra J., Ward R., Tiao G.M. Effect of rotavirus strain on the murine model of biliary atresia. J. Virol. 2007, 81(4):1671-1679.
2. Barnes B.H., Tucker R.M., Wehrmann F., Mack D.G., Ueno Y., Mack C.L. Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. Liver Int. 2008, 29(8):1253-1261.
3. Bezerra J.A., Tiao G., Ryckman F.C., Alonson M., Sabla G.E., Shneider B., Sokol R.J., Aronow B.J. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002, 360:1653-1659.
4. Blutt S.E., Fenaux M., Warfield K.I., Greenberg H.B., Conner M.E. Active viremia in rotavirus-infected mice. J. Virol. 2006, 80(13):6702-6705.
5. Blutt S.E., Matson D.O., Crawford S.E., Staat M.A., Azimi P., Bennett B.L., Piedra P.A., Conner M.E. Rotavirus antigenemia in children is associated with viremia. PLoS Med. 2007, 4(4):e121.
6. Brown L.F., Berse B., VanDeWater L., Papadopoulos-Sergiou A., Perruzzi C.A., Manseau E.J., Dvorak H.F., Senger D.R. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell 1992, 3:1169-1180.
7. Cantor H., Shinohara M. Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat. Rev. Immunol. 2009, 9(2):137-141.
8. Carvalho E., Liu C., Shivakumar P., Sabla G., Aronow B., Bezerra J.A. Analysis of the biliary transcriptome in experimental biliary atresia. Gastroenterology 2005, 129(2):713-717.
9. Crawford S.E., Mukherjee A.K., Estes M.K., Lawton J.A., Shaw A.L., Ramig R.F., Prasad R.V. Trypsin cleavage stabilizes the rotavirus VP4 spike. J. Virol. 2001, 75:6052-6061.
10. Czech-Schmidt G., Verhagen W., Szavay P., Leonhardt J., Petersen C. Immunological gap in the infectious animal model for biliary atresia. J. Surg. Res. 2001, 101:62-67.
11. De Barros A.P., Takiya C.M., Garzoni L.R., Leal-Ferreira M.L., Dutra H.S., Chiarini L.B., Meirelles M.N., Borojevic R., Rossi M.I. Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model. PLoS One 2010, 5(2):e9093.
12. Domiati-Saad R., Dawson D.B., Margraf L.R., Finegold M.J., Weinberg A.G., Rogers B.B. Cytomegalovirus and human herpesvirus 6, but not human papillomavirus, are present in neonatal giant cell hepatitis and extrahepatic biliary atresia. Pediatr. Dev. Pathol. 2000, 3(4):367-373.
13. Drut R., Drut R.M., Gomez M.A., Cueto Rua E., Lojo M.M. Presence of human papillomavirus in biliary atresia. J. Pediatr. Gastroenterol. Nutr. 2008, 27(5):530-535.
14. Estes M.K., Graham D.Y., Gerba C.P., Smith E.M. A plaque assay for the simian rotavirus SA11. J. Gen. Virol. 1979, 43(3):513-519.
15. Fickert P., Stoger U., Fuchsbichler A., Moustafa T., Marchall H.U., Weiglein A., Tsybrovskyy O., Jaeschke H., Zatloukal K., Denk H., Trauner M. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am. J. Pathol. 2007, 171(2):525-536.
16. Fickert P., Theuringer A., Moustafa T., Silbert D., Gumhold J., Tsybrovskyy O., Lebofsky M., Jaeschke H., Denk H., Trauner M. The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice. Lab. Invest. 2010, 90(6):844-852.
17. Glaser S., Wang M., Ueno Y., Venter J., Wang K., Chen H., Alpini G., Holterman A. Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299(3):G769-G777.
18. Groene W.S., Shaw R.D. Psoralen preparation of antigenically intact noninfectious rotavirus particles. J. Virol. Methods 1992, 38:93.
19. Harada K., Ozaki S., Sudo Y., Tsuneyama K., Ohta H., Nakanuma Y. Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis. Pathol. Int. 2003, 53:8-17.
20. Huang L., Wei M.F., Feng J.X. Abnormal activation of OPN inflammation pathway in livers of children with biliary atresia and relationship to hepatic fibrosis. Eur. J. Pediatr. Surg. 2008, 18:224-229.
21. Jafri M., Donnelly B., Bondoc A., Allen S., Tiao G. Cholangiocyte secretion of chemokines in experimental biliary atresia. J. Pediatr. Surg. 2009, 44:500-507.
22. Kalica A.R., James H.D., Kapikian A.Z. Hemagglutination by simian rotavirus. J. Clin. Microbiol. 1978, 7(3):314-315.
23. Li X., O'Regan A.W., Berman J.S. IFN-gamma induction of osteopontin expression in human monocytoid cells. J. Interferon Cytokine Res. 2003, 23(5):259-265.
24. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., Desimone C., Song X.Y., Diehl A.M. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37(2):343-350.
25. Lorena D., Darby I.A., Gadeau A.P., Leen L.L., Rittling S., Porto L.C., Rosenbaum J., Desmouliere A. Osteopontin expression in normal and fibrotic liver; altered liver healing in osteopontin-deficient mice. J. Hepatol. 2006, 44(2):383-390.
26. Mack C.L., Tucker R.M., Sokol R.J., Kotzin B.L. Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin. Immunol. 2005, 115:200-209.
27. Mack C.L., Tucker R.M., Lu B.R., Sokol R.J., Fontenot A.P., Ueno Y., Gill R.G. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006, 44(5):1231-1239.
28. Mahjoub F., Shahsiah R., Ardalan F.A., Iravanloo G., Sani M.N., Zarei A., Monajemzadeh M., Farahmand F., Mamishi S. Detection of Epstein Barr virus by chromogenic in situ hybridization in cases of extra-hepatic biliary atresia. Diagn. Pathol. 2008, 3:19.
29. Mano Y., Ishii M., Kisara N., Kobayashi Y., Ueno Y., Kobayashi K., Hamada H., Toyota T. Duct formation by immortalized mouse cholangiocytes: an in vitro model for cholangiopathies. Lab. Invest. 1998, 78:1467-1468.
30. Mohanty S.K., Ivantes C.A.P., Mourya R., Pacheco C., Bezerra J. Macrophages are targeted by rotavirus in experimental biliary atresia and induce neutrophil chemotaxis by Mip2/Cxcl2. Pediatr. Res. 2010, 67(4):345-351.
31. Nadler E.P., Patterson D., Violette S., Weinreb P., Lewis M., Magid M.S., Greco M.A. Integrin alphavbeta6 and mediators of extracellular matrix deposition are up-regulated in experimental biliary atresia. J. Surg. Res. 2009, 154(1):21-29.
32. Nakai A., Imano M., Takeyama Y., Shiozaki H., Ohyanagi H. An immunohistochemical study of osteopontin in hepatolithiasis. J. Hepatobiliary Pancreat. Surg. 2008, 15:615-621.
33. Petersen C., Biermanns D., Kuske M., Schakel K., Meyer-Junghanel L., Mildenberger H. New aspects in a murine model for extrahepatic biliary atresia. J. Pediatr. Surg. 1997, 32(8):1190-1195.
34. Qiao H., Zhaori G., Jiang Z., Chen Y., Chen Y., Hou D. Detection of group C rotavirus antigen in bile duct and liver tissues of an infant with extrahepatic biliary atresia. Chin. Med. J. 1999, 112(1):93-95.
35. Racanelli V., Rehermann B. The liver as an immunological organ. Hepatology 2006, 42(2):S54-S62.
36. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoint. Am. J. Hyg. 1938, 27:493.
37. Riepenhoff-Talty M., Schaekel K., Clark H.F., Mueller W., Uhnoo I., Rossi T., Fisher J., Ogra P.L. Group A rotaviruses produce extrahepatic biliary atresia in orally inoculated newborn mice. Pediatr. Res. 1993, 33(4 Pt.1):394-399.
38. Riepenhoff-Talty M., Gouvea V., Evans M.J., Svensson L., Hoffenberg E., Sokol R.J., Uhnoo I., Greenberg S.J., Schakel K., Zhaori G., Fitzgerald J., Chong S., el-Yousef M., Nemeth A., Brown M., Piccoli D., Hyams J., Ruffin D., Rossi T. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J. Infect. Dis. 1996, 174(1):8-15.
39. Rollo E.E., Hempson S.J., Bansal A., Tsao E., Habib I., Rittling S.R., Denhardt D.L., Mackow E.R., Shaw R.D. The cytokine osteopontin modulates the severity of rotavirus diarrhea. J. Virol. 2005, 79(6):3509-3516.
40. Sahai A., Malladi P., Melin-Aldana H., Green R.M., Whitington P.F. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G264-G273.
41. Shaw R.D., Hempson S.J., Mackow E.R. Rotavirus diarrhea is caused by nonreplicating viral particles. J. Virol. 1995, 69(10):5946-5950.
42. Shivakumar P., Campbell K.M., Sabla G.E., Miethke A., Tiao G., McNeal M.M., Ward R.L., Bezerra J.A. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J. Clin. Invest. 2004, 114(3):322-329.
43. Sokol R.J., Shepherd R.W., Superina R., Bezerra J.A., Robuck P., Hoofnagle J.H. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 2007, 46(2):566-581.
44. Sun J., Xu Y., Dai Z., Sun Y. Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin. Mol. Cell. Endocrinol. 2009, 313(1-2):64-69.
45. Syn W.K., Choi S.S., Liaskou E., Karaca G.F., Agboola K.M., Oo Y.H., Mi Z., Pereira T.A., Zdanowicz M., Malladi P., Chen Y., Moylan C., Jung Y., Bhattacharya S.D., Teaberry V., Omenetti A., Abdelmalek M.F., Guy C.D., Adams D.H., Kuo P.C., Michelotti G.A., Whitington P.F., Diehl A.M. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 2010, 53(1):106-115.
46. Szalay G., Sauter M., Haberland M., Zuegel U., Steinmeyer A., Kandolf R., Klingel K. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Circ. Res. 2009, 104:851-859.
47. Tyler K.L., Sokol R.J., Oberhaus S.M., Le M., Karrer F.M., Narkewicz M.R., Tyson R.W., Murphy J.R., Low R., Brown W.R. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology 1998, 27(6):1475-1482.
48. Vetrone S.A., Montecino-Rodriguez E., Kudryashova E., Kramerova I., Hoffman E.P., Liu S.D., Miceli M.C., Spencer M.J. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-β. J. Clin. Invest. 2009, 119:1583-1594.
49. Whitington P.F., Malladi P., Melin-Aldana H., Azzam R., Mack C.L., Sahai A. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr. Res. 2005, 57(6):837-844.
50. Zhang M., Zeng C.Q., Morris A.P., Estes M.K. A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells. J. Virol. 2000, 74(24):11663-11670.